Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smits

Showing results (231-240 of 295) with videos related to

Pageof 30
Sort By:
JAMA Cardiology|November 22, 2023
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical TrialAntonio Landi, Mirvat Alasnag, Dik Heg, et al.
JACC. Cardiovascular Interventions|November 27, 2024
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding RiskMarco Roffi, Antonio Landi, Dik Heg, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
Circulation|December 24, 2003
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Patrick W Serruys, Ron T van Domburg, et al.
American Heart Journal|April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trialGeorgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Journal of the American College of Cardiology|May 23, 2025
Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR PatientsDario Bongiovanni, Antonio Landi, Enrico Frigoli, et al.
European Heart Journal|August 29, 2025
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomesTijn J P Heeringa, Romy M J J Hegeman, Yvonne Koop, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Lancet (London, England)|October 31, 2024
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trialDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Pageof 30

Showing results (231-240 of 295) with videos related to

Sort By:
Pageof 30
JAMA Cardiology|November 22, 2023
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical TrialAntonio Landi, Mirvat Alasnag, Dik Heg, et al.
JACC. Cardiovascular Interventions|November 27, 2024
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding RiskMarco Roffi, Antonio Landi, Dik Heg, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
Circulation|December 24, 2003
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Patrick W Serruys, Ron T van Domburg, et al.
American Heart Journal|April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trialGeorgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Journal of the American College of Cardiology|May 23, 2025
Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR PatientsDario Bongiovanni, Antonio Landi, Enrico Frigoli, et al.
European Heart Journal|August 29, 2025
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomesTijn J P Heeringa, Romy M J J Hegeman, Yvonne Koop, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Lancet (London, England)|October 31, 2024
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trialDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Pageof 30